← All trials
NCT05945693
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 15, 2022
- Primary completion
- Dec 31, 2024
- Completion date
- Mar 31, 2025
- First posted
- Jul 14, 2023
- Last posted
- Jul 14, 2023
- Enrollment
- 88
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Universidad de O'HigginsLead sponsor
- Universidad de O'HigginsReponsible party - principal investigator
- Universidad Nacional Andres BelloCollaborator
- University of ChileCollaborator
- University of GuelphCollaborator
- University of ManitobaCollaborator
- Universidad de O'HigginsSponsor investigator
- Universidad de O'HigginsOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.